PHRRF (PharmaTher Holdings) Total Operating Expense: $0.94 Mil (TTM As of Feb. 2026)


What is PharmaTher Holdings Total Operating Expense?

PharmaTher Holdings PHRRF +6.29% Total Operating Expense is $0.94 Mil as of Feb. 2026. The stock has 2 warning signs investors should review.

PharmaTher Holdings's Total Operating Expense for the three months ended in Feb. 2026 was $0.16 Mil. PharmaTher Holdings's Total Operating Expense for the trailing twelve months (TTM) ended in Feb. 2026 was $0.94 Mil.

PharmaTher Holdings Total Operating Expense Related Terms

PharmaTher Holdings Total Operating Expense Historical Data

* Premium members only.

The historical data trend for PharmaTher Holdings's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaTher Holdings Total Operating Expense Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23 May24 May25
Total Operating Expense
2.32 3.19 2.97 2.26 1.13

PharmaTher Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.39 0.24 0.15 0.16

PharmaTher Holdings Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.94 Mil mean?
PharmaTher Holdings (PHRRF) has a Total Operating Expense of $0.94 Mil as of Feb. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on PharmaTher Holdings and its competitors.
Is PharmaTher Holdings' Total Operating Expense too high?
PharmaTher Holdings' current Total Operating Expense is $0.94 Mil.
How does PharmaTher Holdings' Total Operating Expense compare to VRTX and REGN?
PharmaTher Holdings' Total Operating Expense of $0.94 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on PharmaTher Holdings and its competitors. PharmaTher Holdings's current Total Operating Expense is $0.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaTher Holdings stock overvalued right now?
PharmaTher Holdings (PHRRF) has a current Total Operating Expense of $0.94 Mil. The current Total Operating Expense is $0.94 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For PharmaTher Holdings (PHRRF), the current Total Operating Expense is $0.94 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaTher Holdings Business Description

Other Exchanges NCC0:GermanyPHRM:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch and others.